908 Devices (NASDAQ:MASS) Director Christopher Brown Sells 20,000 Shares

908 Devices Inc. (NASDAQ:MASS) Director Christopher Brown sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 6th. The stock was sold at an average price of $7.23, for a total value of $144,600.00. Following the sale, the director directly owned 925,559 shares of the company’s stock, valued at $6,691,791.57. The trade was a 2.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

908 Devices Stock Up 0.2%

Shares of MASS stock opened at $8.08 on Friday. 908 Devices Inc. has a 12 month low of $4.20 and a 12 month high of $9.34. The company has a market cap of $302.60 million, a PE ratio of -8.08 and a beta of 0.57. The business’s 50 day moving average is $6.66 and its two-hundred day moving average is $6.49.

908 Devices (NASDAQ:MASS) last issued its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.01. The business had revenue of $17.38 million during the quarter, compared to analysts’ expectations of $16.19 million. 908 Devices had a negative net margin of 62.40% and a negative return on equity of 13.82%. As a group, equities analysts expect that 908 Devices Inc. will post -0.41 EPS for the current fiscal year.

Hedge Funds Weigh In On 908 Devices

Several large investors have recently bought and sold shares of MASS. Farther Finance Advisors LLC acquired a new stake in 908 Devices in the 3rd quarter worth $28,000. Raymond James Financial Inc. acquired a new position in shares of 908 Devices during the second quarter valued at about $48,000. Daiwa Securities Group Inc. acquired a new position in shares of 908 Devices during the second quarter valued at about $61,000. PCM Encore LLC bought a new stake in shares of 908 Devices in the fourth quarter valued at about $62,000. Finally, The Manufacturers Life Insurance Company bought a new stake in shares of 908 Devices in the second quarter valued at about $77,000. 88.06% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Weiss Ratings upgraded shares of 908 Devices from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, April 13th. Wall Street Zen upgraded 908 Devices from a “hold” rating to a “buy” rating in a research note on Saturday, March 14th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $12.00.

908 Devices Company Profile

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.